Literature DB >> 11013342

1alpha-Hydroxylase and the action of vitamin D.

M Hewison1, D Zehnder, R Bland, P M Stewart.   

Abstract

The active form of vitamin D, 1,25-dihydroxvitamin D(3) (1, 25(OH)(2)D(3)), is a pleiotropic hormone whose actions include the regulation of calcium homeostasis, control of bone cell differentiation and modification of immune responses. Synthesis of 1, 25(OH)(2)D(3) from the major circulating metabolite, 25-hydroxyvitamin D(3) (25(OH)D(3)), is catalysed by a mitochondrial cytochrome P450 enzyme, 25-hydroxyvitamin D-1alpha-hydroxylase (1alpha-OHase). Although 1alpha-OHase is expressed predominantly in the kidney, extra-renal production of 1,25(OH)(2)D(3) has also been demonstrated in tissues such as lymph nodes and skin. The tight regulation of 1alpha-OHase which occurs in both renal and peripheral tissues has made studies of the expression and regulation of this enzyme remarkably difficult. However, the recent cloning of mouse, rat and human cDNAs for 1alpha-OHase (CYP1alpha/Cyp1alpha) has enabled a more thorough characterization of this enzyme. In particular, analysis of the CYP1alpha gene has identified mutations causing the inherited disorder vitamin D-dependent rickets type 1, also known as pseudo-vitamin D deficiency rickets. Studies from our own group have focused on the distribution of 1alpha-OHase in both renal and extra-renal tissues. Data indicate that the enzyme is expressed throughout the nephron, suggesting discrete endocrine and paracrine/autocrine functions. Further immunohistochemical analyses have shown that the enzyme is widely distributed in extra-renal tissues, and this appears to be due to the same gene product as the kidney. Collectively, these observations have raised important new questions concerning the role of 1alpha-OHase in vitamin D signalling at a local level. The relationship between expression of protein for 1alpha-OHase and enzyme activity has yet to be fully characterized and may be dependent on membrane proteins such as megalin. Similarly, elucidation of the mechanisms involved in differential regulation of renal and extra-renal 1,25(OH)(2)D(3) production will be essential to our understanding of the tissue-specific functions of 1alpha-OHase. These and other issues are discussed in the current review.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11013342     DOI: 10.1677/jme.0.0250141

Source DB:  PubMed          Journal:  J Mol Endocrinol        ISSN: 0952-5041            Impact factor:   5.098


  44 in total

Review 1.  Vitamin D and cancer: a review of molecular mechanisms.

Authors:  James C Fleet; Marsha DeSmet; Robert Johnson; Yan Li
Journal:  Biochem J       Date:  2012-01-01       Impact factor: 3.857

2.  Measurement of vitamin D levels in inflammatory bowel disease patients reveals a subset of Crohn's disease patients with elevated 1,25-dihydroxyvitamin D and low bone mineral density.

Authors:  M T Abreu; V Kantorovich; E A Vasiliauskas; U Gruntmanis; R Matuk; K Daigle; S Chen; D Zehnder; Y-C Lin; H Yang; M Hewison; J S Adams
Journal:  Gut       Date:  2004-08       Impact factor: 23.059

Review 3.  The role of vitamin D in the endocrinology controlling calcium homeostasis.

Authors:  James C Fleet
Journal:  Mol Cell Endocrinol       Date:  2017-04-09       Impact factor: 4.102

Review 4.  Identification of tumor-autonomous and indirect effects of vitamin D action that inhibit breast cancer growth and tumor progression.

Authors:  Abhishek Aggarwal; David Feldman; Brian J Feldman
Journal:  J Steroid Biochem Mol Biol       Date:  2017-07-11       Impact factor: 4.292

5.  Cubilin dysfunction causes abnormal metabolism of the steroid hormone 25(OH) vitamin D(3).

Authors:  A Nykjaer; J C Fyfe; R Kozyraki; J R Leheste; C Jacobsen; M S Nielsen; P J Verroust; M Aminoff; A de la Chapelle; S K Moestrup; R Ray; J Gliemann; T E Willnow; E I Christensen
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-20       Impact factor: 11.205

6.  Vitamin D and Atherosclerotic Cardiovascular Disease.

Authors:  Thomas Hiemstra; Kenneth Lim; Ravi Thadhani; JoAnn E Manson
Journal:  J Clin Endocrinol Metab       Date:  2019-04-04       Impact factor: 5.958

7.  Effects of vitamin d on muscle function and performance: a review of evidence from randomized controlled trials.

Authors:  Lars Rejnmark
Journal:  Ther Adv Chronic Dis       Date:  2011-01       Impact factor: 5.091

8.  A randomized trial of cholecalciferol versus doxercalciferol for lowering parathyroid hormone in chronic kidney disease.

Authors:  Sharon M Moe; Akber Saifullah; Robert E LaClair; Sohail A Usman; Zhangsheng Yu
Journal:  Clin J Am Soc Nephrol       Date:  2010-01-07       Impact factor: 8.237

9.  Genetic variants in the vitamin D pathway genes VDBP and RXRA modulate cutaneous melanoma disease-specific survival.

Authors:  Jieyun Yin; Hongliang Liu; Xiaohua Yi; Wenting Wu; Christopher I Amos; Shenying Fang; Jeffrey E Lee; Jiali Han; Qingyi Wei
Journal:  Pigment Cell Melanoma Res       Date:  2016-01-29       Impact factor: 4.693

10.  1,25-Dihydroxy vitamin D and coronary microvascular function.

Authors:  Selene Capitanio; Gianmario Sambuceti; Massimo Giusti; Silvia Morbelli; Giovanni Murialdo; Giacomo Garibotto; Lara Vera; Pietro Ameri; Barbara Repetto; Mehrdad Naseri; Irene Bossert; Maria Teresa Verardi; Michela Massollo; Cecilia Marini
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-11-14       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.